European Society for Medical Oncology (ESMO) Congress, 2021, Online: “Artificial Intelligence to guide prostate cancer therapeutic strategies”
French Society of Radiation Oncology Annual Meeting 2021, Paris: “Predicting Cancer Prevalence with Satellite Imaging and Deep Learning”
Saint-Paul de Vence Prostate cancer annual courses, 2021, Nice: “The role of radiotherapy for cN+ prostate cancer patients”
GEMO annual meeting, 2021, Online: “The impact of AI in oncology”
Webinar sponsored by Janssen, 2021, Online: “AI for prostate cancer management”
American Society for Radiation Oncology 62nd Annual Meeting, 2020, Online: “Predicting survival in prostate cancer patients with interpretable artificial intelligence”
Seminar AIMI Stanford Center, 2020, Online: “Predicting Cancer Prevalence with Satellite Imaging and Deep Learning”
French Society of Radiation Oncology Annual Meeting 2019, Online: “AI applications for prostate cancer management”
Radiation Oncology seminar of the Lille Cancer Center, 2019, Lille: “The impact of AI in radiation oncology”
French Society of Radiation Oncology Annual Meeting 2018, Paris: “Predicting complete pathological response after neoadjuvant chemoradiotherapy in locally-advanced rectal cancer with Radiomics and Deep Learning”
AURORE seminar sponsored by AMGEN, 2018, Paris: “The impact of AI in oncology”
Descartes Erasmus Conference, 2018, Paris: “AI in Oncology, potential and pitfalls”
Paoli Calmette Seminar, 2018, Marseille: “How AI will change cancer research »
Paris Sciences Festival seminar, 2018, Paris: “How AI will change the oncologist’s work”
Prostate cancer seminar sponsored by IPSEN, 2018, Paris: “Treating prostate cancer with radiotherapy”
GI oncology workshop sponsored by Lilly, 2018, Paris: “Treating Stomach cancer with radiotherapy”
Accuray Symposium, ASTRO annual meeting, 2017, San Diego: “TomoTherapy versus RapidArc: Comparison of Clinical Outcomes in Head & Neck Cancers”
Les Rencontres de la Cancérologie Française 2017, Paris: “Predicting Treatment response with heterogeneous data”
AERO webinar, 2017, Online: « TomoTherapy® versus RapidArc: Comparison of Clinical Outcomes in Head and Neck Cancers”
French Association of Urology Annual Meeting 2017, Paris: “CyberKnife to treat nodal relapse in Prostate Cancer”
Ecole Télécom ParisTech Health Seminar, 2017, Paris: “Applications of AI in Oncology”
Rencontres de la Cancérologie Française, 2017, Paris: “Integrating hetereogenous data for AI in oncology”
Healthcare data integration methodologies, France Life Imaging Conference 2017, Orsay: “Radiomics biomarkers for prediction in radiation oncology,”
Artificial intelligence for medical imaging and precision medicine 2017 Conference, Institut Curie: “Applied artificial Intelligence in radiation oncology”
La Paillasse Innovation in healthcare 2017 Conference, Paris: “Deep Learning in Medicine – state of the art”
French Society of Radiation Oncologists 2015 Conference, Paris: « Adaptive radiotherapy for lung cancer »
French Society of Radiation Oncologists 2012 Conference, Paris: « Liver SBRT: predictive factors of efficacy and toxicity »
French Society of Radiation Oncologists 2011 Conference, Paris: « Fiducial-free real-time tumor tracking for early-stage lung cancer stereotactic radiation therapy »
International Society of Radiosurgery Society (ISRS) 2011 Conference, Paris: « Early efficacy and toxicity evaluation of CyberKnife Xsight Lung Treatment »
CyberKnife Robotic Radiosurgery Summit 2011, San Francisco: « Feasibility and Efficacy Evaluation of the CyberKnife Xsight Lung System »
French Society for Gynecological Oncology 2010 Conference (Société Française d'Oncologie Gynécologique), Paris: « Pelvic Tomotherapy for elderly patients: feasability and toxicity »
Young Scientist Session - European Society for Therapeutic Radiology and Oncology 29th Conference, 2010, Barcelona: « Early efficacy and toxicity evaluation of CyberKnife Xsight Lung »